Literature DB >> 28362515

FBP1 is highly expressed in human hypertrophic scars and increases fibroblast proliferation, apoptosis, and collagen expression.

Jieyi Zuo1,2, Zhiying Chen2, Xinchao Zhong3, Wanli Lan2, Yizhen Kuang2, Dong Huang1,2.   

Abstract

PURPOSE: FBP1, one of the far-upstream element binding proteins(FBPs), is a distal upstream binding protein of c-myc, which is highly expressed in tumor tissues. This study aimed to investigate FBP1 expression in human hypertrophic scars and to determine the effects of FBP1 on fibroblasts.
MATERIALS AND METHODS: Human normal skin and scar specimens were collected during clinical surgery. One portion of each tissue specimen was embedded in paraffin and sliced to observe differences in histological features and FBP1 expression by immunohistochemistry and western blotting. The other portion of each tissue specimen was cultured to obtain fibroblasts. Fibroblasts from the second to the sixth passage were used for the experiments, which were divided into the following two groups: an experimental group, whose cells were transfected with an siRNA targeting FBP1, and a control group, whose cells where not transfected. MTT and TUNEL assays were performed, respectively, to assess fibroblast proliferation and apoptosis, and western blotting was performed to assess protein expression.
RESULTS: We obtained fibroblasts by primary tissue culture and found that FBP1 was highly expressed in hypertrophic scars. MTT assay showed that an siRNA targeting FBP1 significantly reduced fibroblast proliferation in siRNA-treated cells compared to control cells. TUNEL assay showed that there was no difference in apoptosis between the two groups; however, western blotting showed that collagen I, collagen III, c-myc, caspase-3, and caspase-9 expression levels were all decreased in the experimental group.
CONCLUSION: FBP1 is highly expressed in human hypertrophic scars and increases fibroblast proliferation, apoptosis and collagen expression.

Entities:  

Keywords:  Apoptosis; C-myc; FBP1; fibroblast; hypertrophic scar; proliferation

Mesh:

Substances:

Year:  2017        PMID: 28362515     DOI: 10.1080/03008207.2017.1311327

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  6 in total

1.  LncRNA-BLACAT1 Facilitates Proliferation, Migration and Aerobic Glycolysis of Pancreatic Cancer Cells by Repressing CDKN1C via EZH2-Induced H3K27me3.

Authors:  Xin Zhou; Wei Gao; Huanhuan Hua; Zhimin Ji
Journal:  Front Oncol       Date:  2020-09-23       Impact factor: 6.244

2.  USP15 Enhances the Proliferation, Migration, and Collagen Deposition of Hypertrophic Scar-Derived Fibroblasts by Deubiquitinating TGF-βR1 In Vitro.

Authors:  Longxiang Tu; Zunwen Lin; Qin Huang; Dewu Liu
Journal:  Plast Reconstr Surg       Date:  2021-11-01       Impact factor: 5.169

3.  MicroRNA-26a inhibits hyperplastic scar formation by targeting Smad2.

Authors:  Jun Qi; Yifei Liu; Kesu Hu; Yi Zhang; Yangyang Wu; Xia Zhang
Journal:  Exp Ther Med       Date:  2018-03-21       Impact factor: 2.447

4.  Inhibition of sphingosine kinase 2 attenuates hypertrophic scar formation via upregulation of Smad7 in human hypertrophic scar fibroblasts.

Authors:  Jian Zeng; Bin Jiang; Xia Xiao; Rou Zhang
Journal:  Mol Med Rep       Date:  2020-07-09       Impact factor: 2.952

5.  A six-herb Chinese medicine composition ointment as a promising candidate for treatment of hypertrophic scars.

Authors:  Zu-Hua Wang; Xue-Yan Sun; Jiao-Jiao Zhang; Francesca Giampieri; Cheng-Ju Jiang; Ting-Ting Feng; Zhi-Wei Wang; Rong-Yi Chen; Maurizio Battino; Ying Zhou
Journal:  Chin Herb Med       Date:  2020-12-29

6.  Interleukin-10-Modified Adipose-Derived Mesenchymal Stem Cells Prevent Hypertrophic Scar Formation via Regulating the Biological Characteristics of Fibroblasts and Inflammation.

Authors:  Fang Xie; Li Teng; Jianjian Lu; Jiajie Xu; Chao Zhang; Liya Yang; Xiaoyang Ma; Minghao Zhao
Journal:  Mediators Inflamm       Date:  2022-06-21       Impact factor: 4.529

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.